Skip to main content
Clinical Trials/IRCT20201121049452N1
IRCT20201121049452N1
Completed
Phase 3

Evaluation of the effect of the combination of Teriparatide and Calcium supplement in comparison with Calcium supplement alone on intertrochanteric fracture healing

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • People over 50 years old with intertrochanteric fractures
  • use Triaparatide for a period of 3 months after surgery
  • Vitamin D with normal serum levels

Exclusion Criteria

  • Teriparatide is prescribed before surgery
  • Teriparatide is prescribed for less than 3 months
  • Unacceptable fracture reduction
  • Multiple fractures
  • Underlying conditions, or self\-medication that affects bone repai
  • Contralateral pelvic fractures
  • Pathological fractures
  • Any anti\-osteoporosis medication (except calcium and vitamin d tablets)
  • Deficiencies in medical records

Outcomes

Primary Outcomes

Not specified

Similar Trials